Order Article Reprints

Pradhan D, Jour G, Milton D, Vasudevaraja V, Tetzlaff MT, Nagarajan P, Curry JL, Ivan D, Long L, Ding Y, et al. Aberrant DNA Methylation Predicts Melanoma-Specific Survival in Patients with Acral Melanoma. Cancers. 2019; 11(12):2031. https://doi.org/10.3390/cancers11122031

Pradhan, Dinesh, George Jour, Denái Milton, Varshini Vasudevaraja, Michael T. Tetzlaff, Priyadharsini Nagarajan, Jonathan L. Curry, Doina Ivan, Lihong Long, Yingwen Ding, and et al. 2019. "Aberrant DNA Methylation Predicts Melanoma-Specific Survival in Patients with Acral Melanoma" Cancers 11, no. 12: 2031. https://doi.org/10.3390/cancers11122031

Pradhan, D., Jour, G., Milton, D., Vasudevaraja, V., Tetzlaff, M. T., Nagarajan, P., Curry, J. L., Ivan, D., Long, L., Ding, Y., Ezhilarasan, R., Sulman, E. P., Diab, A., Hwu, W.-J., Prieto, V. G., Torres-Cabala, C. A., & Aung, P. P. (2019). Aberrant DNA Methylation Predicts Melanoma-Specific Survival in Patients with Acral Melanoma. Cancers, 11(12), 2031. https://doi.org/10.3390/cancers11122031